SXTPNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SXTPW

60 DEGREES PHARMACEUTICALS, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$0.83−0.03 (-3.29%)

Close on Oct 19, 2026

Market cap: $2.20M
P/E (TTM): –
Dividend yield: –

60 DEGREES PHARMACEUTICALS, INC. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash & Equivalents	1.51	1.66	2.14	0.26	0.12
Short-Term Investments	1.24	1.73	–	–	–
Cash & Short-Term Investments	2.75	3.39	2.14	0.26	0.12
Receivables	0.51	0.49	0.23	0.05	–
Inventory	0.66	0.44	0.47	0.52	–
Prepaid Expenses & Other	0.98	1.07	4.40	0	–
Total Current Assets	4.90	5.39	7.24	1.10	–
Property, Plant & Equipment	0.25	0.15	0.06	0.02	–
Gross Property, Plant & Equipment	0.44	0.30	0.21	0.15	–
Accumulated Depreciation	-0.19	-0.15	-0.15	-0.13	–
Machinery & Equipment	–	0.06	–	–	–
Operating Lease Right-of-Use Assets	–	–	0.01	0.01	–
Intangible Assets	0.22	0.16	0.23	0.16	–
Other Long-Term Assets	0.22	0.22	0.48	–	–
Total Assets	5.37	5.76	7.78	1.30	–
Accounts Payable	1.46	1.01	0.51	0.76	–
Current Portion of Long-Term Debt	0.01	0.01	0.01	–	–
Current Debt	0.01	0.01	0.01	–	–
Current Portion of Leases	–	–	0.01	0.01	–
Total Current Liabilities	1.84	1.66	2.84	24	–
Long-Term Debt	0.14	0.15	–	17	–
Operating Lease Liabilities	–	–	0.01	0.01	–
Total Liabilities	1.99	1.80	2.99	25	–
Total Debt	0.15	0.16	0.01	17	–
Preferred Stock	9.57	9.57	9.86	–	–
Common Stock	0.00	0.00	0.00	0.00	–
Additional Paid-In Capital	42	35	27	5.16	–
Retained Earnings	-48	-41	-33	-29	–
Comprehensive Income & Other	0.14	0.14	0.14	0.07	–
Shareholders' Equity	3.46	4.04	4.87	-24	–
Noncontrolling Interest	-0.08	-0.08	-0.07	-0.57	–
Total Equity	3.38	3.96	4.80	-24	-18
Total Liabilities & Equity	5.37	5.76	7.78	1.30	–
Shares Outstanding(shares)	1.16	0.14	0.02	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 19.4%
Operating margin: -774.9%
Net margin: -729.9%
Return on equity, FY2025: -196.4%

Financial strength

Current ratio: 2.32
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 63.7%

Valuation

P/E ratio: –
Price to sales: 1.98
Price to book: 0.84
Dividend yield: –